This brand name is authorized in United States.
The drug MIMRYLO contains one active pharmaceutical ingredient (API):
1
|
UNII
XM71MYX0IQ - RUSFERTIDE
|
|
Rusfertide is a mimetic of the endogenous hormone hepcidin that blocks the iron transporter ferroportin. Inhibition of ferroportin by rusfertide reduces availability of iron for production of red blood cells resulting in lower hematocrit levels. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| MIMRYLO Solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| US | FDA, National Drug Code | 63020-600, 63020-710, 63020-715, 63020-720, 63020-725, 63020-730, 63020-735, 63020-740, 63020-745, 63020-760, 63020-765 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.